MDXXF (Pharmala Biotech Holdings) Pretax Margin % : -836.59% (As of Nov. 2024)

Pharmala Biotech Holdings Pretax Margin % Chart

Pharmala Biotech Holdings Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24	Nov24
Pretax Margin %	Get a 7-Day Free Trial									-18.10	4.74	-246.27	-	-836.59

Competitive Comparison of Pharmala Biotech Holdings's Pretax Margin %

For the Biotechnology subindustry, Pharmala Biotech Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmala Biotech Holdings's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmala Biotech Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Pharmala Biotech Holdings's Pretax Margin % falls into.

Pharmala Biotech Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Pharmala Biotech Holdings's Pretax Margin for the fiscal year that ended in Aug. 2024 is calculated as

Pharmala Biotech Holdings's Pretax Margin for the quarter that ended in Nov. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmala Biotech Holdings  (OTCPK:MDXXF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Pharmala Biotech Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Pharmala Biotech Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmala Biotech Holdings Business Description